Compare Organon Pharma Indonesia Tbk. (SCPI) vs Pelayaran Tamarin Samudra Tbk. (TAMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Pelayaran Tamarin Samudra Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Pelayaran Tamarin Samudra Tbk. trades at Rp28 (market cap 1.05T, 10.88M 24h volume). The key difference: Pelayaran Tamarin Samudra Tbk. is far larger — about 10.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TAMU | |
|---|---|---|
Market Cap | 104.4B | 1.05T |
Volume | — | 10.88M |
Lot | — | 108.83K |
Turnover | — | 300.23M |
Average Price | — | 27.59 |
Value | — | 300.23M |
Indicative Equilibrium Price | — | 28 |
Indicative Equilibrium Volume | — | 8.09K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Pelayaran Tamarin Samudra Tbk.
PT Pelayaran Tamarin Samudra Tbk (the Company) was established based on the Deed of Notary Linda Ibrahim, SH, No. 38 dated August 27, 1998. The company services are include offshore marine support such as chartering, re-chartering and transshipment services of Accommodation Work Barge (AWB), Anchor Handling Towing Supply (AHTS).
Read more on TAMU →
